The role of the Molecular Imaging Committee is to facilitate support to increase capability and capacity of medical imaging for research. The committee will identify the key priorities and implement strategies to achieve these.
The Molecular Imaging Committee is one of the Translational Platforms to develop Tomorrow’s Healthcare as articulated in the MACH Strategy 2020 to 2025.
Priorities for the Molecular Imaging Committee include:
- Developing strategies to become a major influential body for molecular imaging in Australia
- Identifying gaps in molecular imaging expertise to benefit the MACH network
- Identifying gaps and developing a strategy to advise on infrastructure requirements
- Enabling the collaboration of chemists and clinician researchers to identify research priorities
- Enabling the accessibility to molecular imaging research for interested investigators
- Identifying and mentor the next generation of molecular imaging researchers
- Acting as a resource to provide expert advice to ethics and scientific meetings.
|Professor Ashley Bush||The Florey Institute||Full Bio|
|Professor Paul Donnelly||University of Melbourne||Full Bio|
|Professor Rodney Hicks||St Vincent’s||Full Bio|
|Associate Professor Nathan Lawrentschuk||Austin Health||Full Bio|
|Professor Michael Macmanus||Peter MacCallum Cancer Centre||Full Bio|
|Professor Christopher Rowe||The Florey Institute||Full Bio|
|Professor Andrew Scott AM||Austin Health||Full Bio|
|Professor Jonathan White||University of Melbourne||Full Bio|